SCHEMBL467527

SCHEMBL467527

C[C@H](O)[C@@H](O)CCC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7154944 1.00
SCHEMBL489139 1.00
SCHEMBL4310324 1.00
SCHEMBL11067254 1.00
SCHEMBL17984919 0.85 ALDH1A1 (0.32)
SCHEMBL17984925 0.85 HIF1A (0.41)
Iodide SCHEMBL30151177 0.83 HIF1A (0.39)
SCHEMBL11902617 0.81 TSHR (0.44)
SCHEMBL28569086 0.81
SCHEMBL749955 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 384 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025083657-A1 LIPID COMPOUND AND COMPOSITION FOR TISSUE-SPECIFIC DELIVERY OF ACTIVE SUBSTANCE 한국생명공학연구원 2025-04-24 WO claimed
EP-3328439-A1 MULTILIGAND AGENT FOR DRUG DELIVERY Arcturus Therapeutics, Inc. (US) 2018-06-06 EP claimed
WO-2017023817-A1 MULTILIGAND AGENT FOR DRUG DELIVERY ARCTURUS THERAPEUTICS, INC. (US) 2017-02-09 WO claimed
US-7538092-B2 Pharmaceutically active oligosaccharide conjugates FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2009-05-26 US claimed
EP-1549350-B1 PHARMACEUTICALLY ACTIVE OLIGOSACCHARIDE CONJUGATES FRESENIUS KABI DE GMBH (DE) 2008-09-24 EP claimed
US-20070059689-A1 Hybrid glycosylated products and their production and use UNIVERSIDAD DE OVIEDO (ES) 2007-03-15 US claimed
US-20060100163-A1 Pharmaceutically active oligosaccharide conjugates FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2006-05-11 US claimed
US-20050267169-A1 Watersoluble prodrugs of propofol FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2005-12-01 US claimed
EP-1554242-A1 WATERSOLUBLE PRODRUGS OF PROPOFOL Fresenius Kabi Deutschland GmbH (DE) 2005-07-20 EP claimed
EP-1549350-A1 PHARMACEUTICALLY ACTIVE OLIGOSACCHARIDE CONJUGATES Fresenius Kabi Deutschland GmbH (DE) 2005-07-06 EP claimed
WO-1991019725-A2 HETEROCYCLIC ANTHRACYCLIONE AND ANTHRACYCLINE ANALOGS BIOCHEM PHARMA INC. (CA) 1991-12-26 WO claimed
EP-0131181-B1 ANTHRACYCLIN DERIVATIVES, MICROBIOLOGICAL METHOD FOR THEIR PREPARATION AND THEIR USE AS CYTOSTATIC AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 1990-03-07 EP claimed
EP-0167935-B1 ANTHRACYCLINE DERIVATIVES, A PROCESS FOR THE PRODUCTION THEREOF, A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND THEIR USE AS MEDICAMENTS MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) 1989-08-30 EP claimed
EP-0186807-B1 ANTHRACYCLINE DERIVATIVES, THEIR MICROBIOLOGICAL PREPARATION AND THEIR USE AS MEDICINES HOECHST AKTIENGESELLSCHAFT (DE) 1989-08-16 EP claimed
EP-0207463-A2 Anthracyclin tetrasaccharides, method for their preparation and their use as cytostatic agents HOECHST AKTIENGESELLSCHAFT (DE) 1987-01-07 EP claimed
EP-0186807-A2 Anthracycline derivatives, their microbiological preparation and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1986-07-09 EP claimed
EP-0167954-A2 1-Hydroxy-cytorhodines, a microbiological method for their preparation and their use as cytostatic agents HOECHST AKTIENGESELLSCHAFT (DE) 1986-01-15 EP claimed
EP-0131181-A2 Anthracyclin derivatives, microbiological method for their preparation and their use as cytostatic agents HOECHST AKTIENGESELLSCHAFT (DE) 1985-01-16 EP claimed
EP-0022574-B1 RHODOMYCIN-GROUP OF ANTIBIOTICS AND PROCESS FOR PREPARING SAME SANRAKU-OCEAN CO., LTD. (JP) 1984-02-29 EP claimed
EP-0022574-A1 Rhodomycin-group of antibiotics and process for preparing same SANRAKU-OCEAN CO., LTD. (JP) 1981-01-21 EP claimed